中文 | English
Return
Total: 31 , 1/4
Show Home Prev Next End page: GO
MeSH:(Immunologic Factors/administration )

1.Predictive Value of Tumor Mutation Burden in Immunotherapy for Lung Cancer.

Huanlan SA ; Kewei MA ; Yong GAO ; Deqiang WANG

Chinese Journal of Lung Cancer 2019;22(6):380-384

2.New Advances in the Treatment for Small Cell Lung Cancer.

Xiaoxia CUI ; Peng SONG ; Li ZHANG

Chinese Journal of Lung Cancer 2019;22(6):355-362

4.Combined group A streptococcus preparation (sapylin) and cisplatin for malignant peritoneal effusion.

Jing PAN

Chinese Journal of Oncology 2005;27(7):442-444

5.Aureobasidium-Derived Soluble Branched (1,3-1,6) beta-Glucan (Sophy beta-glucan) Enhances Natural Killer Activity in Leishmania amazonensis-Infected Mice.

Lalani YATAWARA ; Susiji WICKRAMASINGHE ; Mitsuru NAGATAKI ; Misa TAKAMOTO ; Haruka NOMURA ; Yasunori IKEUE ; Yoshiya WATANABE ; Takeshi AGATSUMA

The Korean Journal of Parasitology 2009;47(4):345-351

6.Evolution of Myelofibrosis Treatment.

Ki Seong EOM

Korean Journal of Medicine 2016;90(4):293-297

7.Immunomodulatory function of orally administered thymosin alpha1.

Xiang-Ming CHEN ; Han-Liang JIANG ; Lin-Fu ZHOU ; Xiao-Ping PAN ; Zhong-Rong HU ; Rong-Hua LIU ; Xiao-Ming CHEN ; Zhi CHEN

Journal of Zhejiang University. Science. B 2005;6(9):873-876

8.Clinical study of early interventions for ABO hemolytic disease of the newborn.

Wei-min HUANG ; Hong-wu CHEN ; Ning LI ; Ming YANG ; Pei-yan JIAO

Journal of Southern Medical University 2006;26(9):1350-1355

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 31 , 1/4 Show Home Prev Next End page: GO